Literature DB >> 32347970

The association between serum albumin/prealbumin level and disease severity in non-CF bronchiectasis.

Liyang Li1, Zhuozhe Li1, Jing Bi1, Huayin Li1, Sijiao Wang1, Changzhou Shao1,2, Yuanlin Song1.   

Abstract

Non-cystic fibrosis (non-CF) bronchiectasis is a chronic pulmonary disease that can lead to malnutrition. Serum prealbumin and albumin level are related to inflammatory and nutritional status. Thus, we aimed to confirm our hypothesis that low serum albumin and prealbumin level, as well as body mass index (BMI), is correlated to severe non-CF bronchiectasis. We conducted a retrospective cross-sectional study of 128 patients, including 75 patients with prealbumin test and 79 patients with albumin test. Detailed medical history was recorded, including pulmonary function tests and high-resolution computed tomography. bronchiectasis severity index (BSI) and FACED scores were calculated. Leicester Cough Questionnaire, Quality of Life Questionnaire-Bronchiectasis, chronic obstructive pulmonary disease (COPD) assessment test and Patient Health Questionnaire-9 questionnaires were used to assess patients' clinical symptoms. Correlation analysis showed that BSI score was more correlated to patients' clinical symptoms than FACED. Thus, patients were divided into three groups of different severity based on BSI score. Albumin, prealbumin and BMI showed a significant difference between three groups. Correlation and multivariable linear regression analysis showed that serum albumin and prealbumin level were correlated to BSI, FACED and questionnaires. The analysis between three indices and PFT/high-resolution computed tomography (HRCT) showed that prealbumin, albumin and BMI could reflect the PFT and modified Reiff score in non-CF bronchiectasis. In conclusion, BMI, albumin and prealbumin showed a significant correlation with the BSI, FACED, as well as patients' clinical symptoms. Among them, serum albumin was the indicator most strongly associated with the BSI and questionnaires, while prealbumin could better reflect lung function decline and radiological severity.
© 2020 John Wiley & Sons Australia, Ltd.

Entities:  

Keywords:  albumin; body mass index; non-CF bronchiectasis; prealbumin

Year:  2020        PMID: 32347970     DOI: 10.1111/1440-1681.13331

Source DB:  PubMed          Journal:  Clin Exp Pharmacol Physiol        ISSN: 0305-1870            Impact factor:   2.557


  4 in total

1.  Serum albumin is a predictor of respiratory hospitalization in patients with bronchiectasis.

Authors:  Sunmi Ju; Jong Hwan Jeong; Manbong Heo; I Re Heo; Tae Hoon Kim; Ho Cheol Kim; Jung-Wan Yoo; Yu Ji Cho; Yi Yeong Jeong; Jong Deog Lee; Seung Jun Lee
Journal:  Chron Respir Dis       Date:  2021 Jan-Dec       Impact factor: 2.444

2.  Supplementation of serum albumin is associated with improved pulmonary function: NHANES 2013-2014.

Authors:  Sheng Hu; Qiang Guo; Silin Wang; Wenxiong Zhang; Jiayue Ye; Lang Su; Sheng Zou; Deyuan Zhang; Yang Zhang; Dongliang Yu; Jianjun Xu; Yiping Wei
Journal:  Front Physiol       Date:  2022-10-03       Impact factor: 4.755

3.  Prevalence and clinical implications of bronchiectasis in patients with overlapping asthma and chronic rhinosinusitis: a single-center prospective study.

Authors:  Haiyan Sheng; Xiujuan Yao; Xiangdong Wang; Yuhong Wang; Xiaofang Liu; Luo Zhang
Journal:  BMC Pulm Med       Date:  2021-07-05       Impact factor: 3.317

4.  The 6-minute walk test predicts mortality in a pulmonary nontuberculous mycobacteria-predominant bronchiectasis cohort.

Authors:  Rebekah A Blakney; Emily E Ricotta; Dean Follmann; Jessica Drew; Kelly A Carey; Lisa N Glass; Chevalia Robinson; Sandra MacDonald; Pamela J McShane; Kenneth N Olivier; Kevin Fennelly; D Rebecca Prevots
Journal:  BMC Infect Dis       Date:  2022-01-21       Impact factor: 3.090

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.